← Back to headlines
Gorilla, Evolv, and Ambarella Stocks React to Mixed Earnings Guidance
Gorilla Therapeutics dropped 11% despite strong 2027 revenue forecasts, while Evolv Technologies and Ambarella saw modest gains amid sector rotation.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
